Multiple secondary data analyses of TORDIA have identified important predictors of treatment response and relapse .
To up date a comparative effectiveness review ( 1980–2011 ) of treatments for adolescents whose depressive episode or disorder ( MDE/MDD ) did not respond to one or more trials of SSRI antidepressants .
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.
OBJECTIVE Nonadherence to antidepressant treatment may contribute to poor outcome and to suicidal adverse events in adolescent depression . We examine the relationship between adherence and both clinical response and suicidal events in participants in the Treatment of Resistant Depression in Adolescents ( TORDIA ) study . METHOD The relationship between adherence to medication and clinical outcome was assessed in 190 treatment-resistant depressed adolescents who were r and omized to one of four cells : switch to another selective serotonin reuptake inhibitor ( SSRI ) , switch to venlafaxine , or either of these two medication switches plus cognitive behavioral therapy .  Plasma levels of antidepressant drug and metabolites were determined after 6 and 12 weeks of treatment . A twofold or greater variation in the dose-adjusted concentration of drug plus metabolites ( level/dose ratio [ LDR ] ) was defined as nonadherence . Nonadherence was also determined by clinician pill counts ( CPC ) of the proportion of prescribed pills that were unused and was defined as having greater than 30 % of the prescribed pills remaining . RESULTS LDR and CPC showed low concordance . LDR was unrelated to clinical response .  CPC adherence was related to a higher response rate overall ( adherent , 63.0 % versus nonadherent , 47.2 % , p = .03 ) . Approximately half ( 50.8 % ) of the sample surveyed showed evidence of nonadherence by CPC . Neither measure of adherence was related to the occurrence of suicidal events or to the pace of decline in suicidal ideation . CONCLUSIONS Clinician pill counts may be a relevant measure of adherence that is related to outcome under formal clinical trial conditions in depressed adolescents . Nonadherence appears to be a common and significant source of treatment nonresponse . Clinical Trial Registration Information-Treatment of SSRI-Resistant Depression in Adolescents ( TORDIA ) ; http://www . clinical trials.gov ; NCT00018902
Multiple secondary data analyses of TORDIA have identified important predictors of treatment response and relapse .
To up date a comparative effectiveness review ( 1980–2011 ) of treatments for adolescents whose depressive episode or disorder ( MDE/MDD ) did not respond to one or more trials of SSRI antidepressants .